These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
818 related items for PubMed ID: 15510610
1. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients. Ebert W, Muley T, Herb KP, Schmidt-Gayk H. Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610 [Abstract] [Full Text] [Related]
2. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients. Tang C, Liu Y, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X. Clin Chim Acta; 2013 Nov 15; 426():102-7. PubMed ID: 24055775 [Abstract] [Full Text] [Related]
5. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer. Tähtelä R, Thölix E. Anticancer Res; 1996 Nov 15; 16(4B):2289-93. PubMed ID: 8694558 [Abstract] [Full Text] [Related]
6. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels]. Imai T, Honda M, Maeda S, Hosoya Y, Arai T, Sumi S, Umeda H, Yano M, Koga F, Arai K, Yoshida K. Nihon Hinyokika Gakkai Zasshi; 1998 Apr 15; 89(4):484-91. PubMed ID: 9597867 [Abstract] [Full Text] [Related]
9. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer. Akimoto S, Akakura K, Shimazaki J. Jpn J Clin Oncol; 1996 Jun 15; 26(3):157-63. PubMed ID: 8656556 [Abstract] [Full Text] [Related]
10. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy. Zissimopoulos A, Stellos K, Matthaios D, Petrakis G, Parmenopoulou V, Babatsikou F, Matthaiou E, Theodosiadou E, Hountis P, Koutis C. J BUON; 2009 Jun 15; 14(3):463-72. PubMed ID: 19810140 [Abstract] [Full Text] [Related]
11. Carboxy-terminal telopeptide (CTX) and amino-terminal propeptide (PINP) of type I collagen as markers of bone metastases in patients with non-small cell lung cancer. Lumachi F, Santeufemia DA, Del Conte A, Mazza F, Tozzoli R, Chiara GB, Basso SM. Anticancer Res; 2013 Jun 15; 33(6):2593-6. PubMed ID: 23749913 [Abstract] [Full Text] [Related]
12. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. Guañabens N, Parés A, Alvarez L, Martínez de Osaba MJ, Monegal A, Peris P, Ballesta AM, Rodés J. J Bone Miner Res; 1998 Apr 15; 13(4):731-8. PubMed ID: 9580479 [Abstract] [Full Text] [Related]
13. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer. Korpela J, Tiitinen SL, Hiekkanen H, Halleen JM, Selander KS, Väänänen HK, Suominen P, Helenius H, Salminen E. Anticancer Res; 2006 Apr 15; 26(4B):3127-32. PubMed ID: 16886645 [Abstract] [Full Text] [Related]
14. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer. Noguchi M, Noda S. J Urol; 2001 Sep 15; 166(3):1106-10. PubMed ID: 11490307 [Abstract] [Full Text] [Related]
15. Biochemical markers of bone turnover in Camurati-Engelmann disease: a report on four cases in one family. Hernández MV, Peris P, Guañabens N, Alvarez L, Monegal A, Pons F, Ponce A, Muñoz-Gómez J. Calcif Tissue Int; 1997 Jul 15; 61(1):48-51. PubMed ID: 9192513 [Abstract] [Full Text] [Related]
16. [Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) for diagnosis of bone metastasis in patients with primary lung cancer]. Yokoyama T, Yamamoto M, Shima K, Suzuki K, Sako C, Ito G, Kume M, Maeda M. Nihon Kokyuki Gakkai Zasshi; 2003 Dec 15; 41(12):857-60. PubMed ID: 14727545 [Abstract] [Full Text] [Related]
17. Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy--a randomized trial. Rief H, Omlor G, Akbar M, Bruckner T, Rieken S, Förster R, Schlampp I, Welzel T, Bostel T, Roth HJ, Debus J. BMC Cancer; 2016 Mar 17; 16():231. PubMed ID: 26983672 [Abstract] [Full Text] [Related]
18. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM. J Bone Miner Res; 1995 Mar 17; 10(3):458-65. PubMed ID: 7785468 [Abstract] [Full Text] [Related]
19. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Miki T, Kim M, Nishizawa Y. Am J Kidney Dis; 2002 Oct 17; 40(4):802-9. PubMed ID: 12324916 [Abstract] [Full Text] [Related]
20. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M, Fukunaga M, Ohtawa T, Harada T. World J Surg; 1996 Sep 17; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [Abstract] [Full Text] [Related] Page: [Next] [New Search]